NCT05690048
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05690048
Title Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA) (FLORA)
Acronym FLORA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Michael Dill
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
University Hospital Heidelberg RECRUITING Heidelberg Baden-Wurttemberg 69120 Germany Details
University Hospital Augsburg NOT_YET_RECRUITING Augsburg 86156 Germany Details
University Hospital Essen NOT_YET_RECRUITING Essen 45147 Germany Details
University Hospital Mannheim NOT_YET_RECRUITING Mannheim 68167 Germany Details
University Hospital Regensburg NOT_YET_RECRUITING Regensburg 93053 Germany Details
University Hospital Tübingen NOT_YET_RECRUITING Tübingen 72076 Germany Details
University Hospital Ulm NOT_YET_RECRUITING Ulm 89081 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field